Avonex Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

A Phase IIIb, Multicenter, International, Randomized, Assessor-blind, Active-controlled Parallel Arm Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Comparison to Interferon Beta-1a (REBIF ®) in Patients With RRMS
Condition:   Multiple Sclerosis, Relapsing-Remitting Interventions:   Drug: Enkorten;   Drug: REBIF Sponsors:   Bosnalijek D.D;   MonitorCRO Not yet recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2017 Category: Research Source Type: clinical trials